ROSEN, NATIONAL TRIAL LAWYERS, Encourages Charles River Laboratories International, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CRL

Key Facts

• , /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Charles River Laboratories International, Inc. (NYSE: CRL) between May 5, 2020 and February 21, 2023, both dates inclusive (the "Class Period"), of the important July 18, 2023 lead plaintiff deadline.
• SO WHAT: If you purchased Charles River securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
• The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
• DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Charles River had engaged in illegal activity with respect to its importation of non-human primates for research; (2) as a result, Charles River was at a heightened risk of criminal and regulatory investigation by, inter alia, the U.S.

Click To Read Full Article